Ethifarm Competitors and Similar CompaniesClear all

Ethifarm's competitors and similar companies include Hypera Pharma, CR Sanjiu, Eladiet and Auxulin Pharmaceuticals.

	Ethifarm Ethifarm is a developer and manufacturer of pharmaceutical products.	Hypera Pharma Hypera Pharma is a pharmaceutical company that provides medicines and food supplements.	CR Sanjiu China Resources Sanjiu Medical & Pharmaceutical (CR Sanjiu, 华润三九医药股份有限公司)	Eladiet Eladiet (also known as Elaborados Dietéticos) is a company developing food supplements.	Auxulin Pharmaceuticals Auxulin Pharmaceuticals is a pharmaceutical company seeking to augment traditional insulin therapy used in the treatment of diabetes.
Founding Date	Founding Date 2004	Founding Date 2001	Founding Date 1985	Founding Date 1985	Founding Date 2017
Type	Type Private	Type Public	Type Public	Type Subsidiary	Type Private
Tags	Tags Manufacturing & Industrial drug development pharma supplements	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial biotech drug development pharma	Tags Manufacturing & Industrial diabetes drug development pharma supplements
Locations	Locations Swadzim, PL HQ Poznań, PL	Locations São Paulo, BR HQ	Locations Shenzhen, CN HQ	Locations Barcelona, ES HQ	Locations Chesterland, US HQ
Employees	Employees 244% increase	Employees 10,481	Employees 20,031	Employees 1242% increase	Employees 325% decrease
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) R$7.7b (FY, 2025)	Revenue (est.) ¥30.1b (FY, 2025)	Revenue (est.) €15.9m (FY, 2017)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods R$2.8b (FY, 2025)	Cost of goods ¥14.5b (FY, 2025)	Cost of goods €5.7m (FY, 2017)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit R$4.9b (FY, 2025)	Gross profit ¥16.7b (FY, 2025)	Gross profit €10.2m (FY, 2017)	Gross profit N/A
Net income	Net income N/A	Net income R$1.2b (FY, 2025)	Net income ¥4.2b (FY, 2025)	Net income €2.3m (FY, 2017)	Net income N/A